The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 15, 2023

Filed:

May. 11, 2021
Applicant:

Epizon Pharma, Inc., New York, NY (US);

Inventors:

James A. Tumlin, Lawrenceville, GA (US);

Paul L. Darke, Hingham, MA (US);

John M. Rudey, New York, NY (US);

Assignee:

Epizon Pharma, Inc., New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/122 (2006.01); A61K 31/05 (2006.01); A61P 13/12 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61P 3/14 (2006.01); A61P 3/10 (2006.01); A61P 43/00 (2006.01); A61K 31/22 (2006.01); A61K 31/366 (2006.01);
U.S. Cl.
CPC ...
A61K 31/122 (2013.01); A61K 9/0053 (2013.01); A61K 31/05 (2013.01); A61K 31/22 (2013.01); A61K 31/366 (2013.01); A61P 3/10 (2018.01); A61P 3/14 (2018.01); A61P 13/12 (2018.01); A61P 43/00 (2018.01); A61K 45/06 (2013.01); A61K 2300/00 (2013.01);
Abstract

The invention provides methods and compositions for preventing or treating (e.g., slowing the progression of, arresting, and/or reversing) tissue calcification in a subject in need thereof and, more particularly, the invention relates to methods of using menaquinone-7 (MK-7) and/or menaquinol-7 (MKH2-7) for preventing or treating (e.g., slowing the progression of, arresting, and/or reversing) tissue calcification in a subject with diabetes, chronic kidney disease, end stage renal failure, or a subject undergoing hemodialysis and/or receiving anticoagulant therapy. The invention further provides methods and compositions for reducing one or more symptoms of chronic obstructive pulmonary disorder (COPD), including using menaquinone-7 (MK-7) and/or menaquinol-7 (MKH2-7), for preventing or treating (e.g., slowing the progression of, arresting, and/or reversing) one or more symptoms of COPD.


Find Patent Forward Citations

Loading…